Sign in to view content

A Randomized Trial of Intravitreous Anti-VEGF for Prevention of Vision Threatening Complications of Diabetic Retinopathy (Protocol W)

Raj K. Maturi, MD

Video
Published 2021

Related

Does the Diabetic Status Influence the Rate of Cataract Surgery Following Pars Plana Vitrectomy Surgery?
Ahmed Sallam, MD PhD FRCOphth
On Demand Cases, Courses, and Papers
2019
Imaging, Digital, Angiography Symposium 1
Annual Meeting Talks
2020
Prophylaxis Intravitreal Aflibercept Against Conversion to Neovascular AMD in High-Risk Eyes (PRO-CON): 24-Month Results
Jeffrey S. Heier, MD
Annual Meeting Talks
2019

Category: Pharmacology

See more